IKS Health has entered into a definitive agreement to acquire 100% of the equity of TruBridge Inc. through its U.S. arm. The acquisition is a strategic move to create a comprehensive "system of record plus system of action" platform. The strategic rationale is driven by the desire to diversify the acquirer's portfolio into sticky, recurring SaaS-based Electronic Health Record (EHR) segments while deepening its penetration into the rural and community hospital market. By integrating TruBridge’s established EHR backbone with IKS Health’s proprietary AI-driven clinical enablement tools, the combined entity aims to solve complex operational challenges for healthcare organizations. This transaction follows the acquirer's successful playbook of acquiring documentation services and RCM providers, marking its first move into proprietary EHR assets. The deal will facilitate significant cross-selling opportunities, allowing the acquirer to deploy its suite of care-enablement software into the target's extensive installed base of community hospital clients, thereby cementing a more defensible market position within the U.S. healthcare technology landscape.

TRUBRIDGE, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN discount to the average currently observed in the TMT (Tech, Media, Telecom) sector (12.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.